Read + Share
Beyer GV, Hueser S, Li R, Manika D, et al. Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen
reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors. Surgery 2024;175:605-612.
PMID: 37914572
|
 |
|
Beyer GV, Hueser S, Li R, Manika D, et al. Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen
reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors. Surgery 2024;175:605-612.
PMID: 37914572
|
|
|
|